Eckuity

Eckuity is a venture capital firm established in 2021 and headquartered in New York, New York. The firm specializes in strategic investments that aim to transform innovative scientific advancements into future healthcare solutions. Eckuity focuses on various sectors, including business-to-consumer markets, healthcare, information technology, 3D printing, artificial intelligence, digital health, health technology, the Internet of Things, life sciences, and robotics. Its investment strategy targets opportunities across the United States, Europe, and Asia, positioning Eckuity as a key player in advancing healthcare technologies and related fields. As a Registered Investment Adviser, the firm is committed to fostering growth in industries that enhance human health and well-being.

Alexander Chikin

Partner and Vice President Investments

Vishal Jain

Managing Partner

Lokman Ouijdani

Venture Partner

Michael Rossbach Ph.D

Venture Partner

Victoria Rutson MD

Partner

Youssef Sebban

Managing Partner

Daniel Vial

Venture Partner

Yuval Binur Ph.D

Venture Partner

7 past transactions

Ansella Therapeutics

Seed Round in 2024
Ansella Therapeutics is a pharmaceutical company dedicated to women's health. It develops treatments using materials science innovations, focusing on improving vaginal health across different life stages. The company offers over-the-counter and prescription products designed to enhance vaginal health and has a proprietary lubricant that leverages cholesterol and fatty acids to maintain cellular properties in the vaginal epithelium, facilitating effective clinical treatment of various vaginal conditions.

Avive

Venture Round in 2024
Avive Solutions, Inc., established in 2017, is a medical technology company based in San Francisco, California. It specializes in the development of Automated External Defibrillators (AEDs) and accompanying software solutions. Avive's primary focus is to remove barriers and simplify the response to Sudden Cardiac Arrest (SCA), empowering anyone to effectively intervene in such emergencies. Their next-generation AED is designed to be easily accessible, user-friendly, and well-maintained, with a connected platform that facilitates data transfer to emergency services and medical professionals, enhancing post-rescue care.

Awak

Series B in 2023
AWAK Technologies Inc. is a medical technology company based in Singapore that specializes in the development of wearable dialysis devices for patients with end-stage renal disease. Established in 2008, the company focuses on creating ultraportable dialysis machines that utilize sorbent technology to regenerate and reconstitute used dialysis fluid, effectively providing the necessary clearances for uremic toxins. The Automated Wearable Artificial Kidney (AWAK) is designed to be lightweight, battery-operated, and capable of continuous operation similar to a natural kidney. This innovation allows patients to maintain their daily routines without the restrictions commonly associated with traditional dialysis methods. AWAK Technologies has completed its research and development phase and is currently advancing through clinical trials, aiming for certifications from regulatory bodies. The engineering and development of its products are conducted in collaboration with local educational institutions, underscoring its commitment to innovation in chronic kidney disease management.

Sanoculis

Series C in 2023
Sanoculis is a medical device start-up based in Tel Aviv, Israel, specializing in innovative solutions for glaucoma treatment. Founded in 2012, the company has developed the Minimally Invasive Micro Sclerostomy (MIMS), a surgical procedure that employs a single-use sterile tool and a multi-use external machine. This technique creates a sclero-corneal drainage channel aimed at reducing intraocular pressure with minimal complications. MIMS utilizes a cutting and drilling device designed to lessen trauma to surrounding tissue, thereby minimizing scar formation and facilitating the creation of a durable filtering bleb. The MIMS approach represents an advanced method in laser sclerotomy, offering healthcare professionals a new alternative for managing glaucoma effectively.

Sonrai Analytics

Venture Round in 2022
Sonrai Analytics is a developer of an advanced analytics software platform focused on harnessing the power of data to enhance research and business outcomes. By integrating artificial intelligence and machine learning, Sonrai aims to transform data analysis into predictive insights. The platform is designed to meet the demands of precision analytics while ensuring reproducibility of data findings. It efficiently utilizes the extensive data generated in various business models, enabling organizations to move away from outdated methods. This empowers companies to tackle complex challenges and discover competitive advantages, while also facilitating the identification of new treatments and accelerating research development.

Mobius Biomedical

Venture Round in 2022
Mobius Biomedical plans to bring unprecedented efficiencies to the development and manufacturing of biologics and biosimilars, and reduce their cost by over 90% at commercial scale. The Company has developed new design, new process and new equipment to drastically reduce the capex, opex and facility footprint of manufacturing plants while maintaining the purity, throughput and efficiency at commercial scale.

Professional Triathletes Organisation

Series B in 2022
Professional Triathletes Organisation is a nonprofit company that organizes events of the triathlon sport.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.